Nolan Mangini Siobhan 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Mar 6, 2023
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-02+76,000→ 76,000 total - Award
Stock Option (Right to Buy)
2023-03-02+228,000→ 228,000 totalExercise: $4.36Exp: 2033-03-01→ Common Stock (228,000 underlying) - Award
Stock Option (Right to Buy)
2023-03-02+200,000→ 200,000 totalExercise: $4.36Exp: 2033-03-01→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock issuable upon the vesting and settlement of restricted stock units ("RSUs"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027.
- [F2]The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis.
- [F3]1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the "2023 Grant Date"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date.